Frank Mengis
Vermögen: 288 049 $ am 31.07.2026
Vermögen: 288 049 $ am 31.07.2026
Frank Mengis is Chief Operating Officer & Deputy CEO at Ypsomed Holding AG since 2015 and Director at Nemis Technologies AG since 2021.
Former roles include Director at Qualitech AG from 2017 to 2021 and Executive Vice President-Global Operations at Nobel Biocare Holding AG.
Education includes a graduate degree from the University of Karlsruhe.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 605 ( 0 % ) | 288 049 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| YPSOMED HOLDING AG | Geschäftsführer | 01.10.2015 |
Nemis Technologies AG
Nemis Technologies AG Miscellaneous Commercial ServicesCommercial Services Develops diagnostic kits and solutions | Direktor/Vorstandsmitglied | 01.06.2021 |
| Unternehmen | Position | Ende |
|---|---|---|
Qualitech AG
Qualitech AG Miscellaneous Commercial ServicesCommercial Services Operates as a material testing center company | Direktor/Vorstandsmitglied | 01.01.2021 |
| NOBEL BIOCARE HOLDING AG | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Nobel Biocare Holding AG
Nobel Biocare Holding AG Medical SpecialtiesHealth Technology Manfuctures and markets dental equipment, supplies, implants and devices | Health Technology |
Ypsomed Holding AG
Ypsomed Holding AG Medical SpecialtiesHealth Technology Manufactures injections and diagnostic devices | Health Technology |
University of Karlsruhe
University of Karlsruhe Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Qualitech AG
Qualitech AG Miscellaneous Commercial ServicesCommercial Services Operates as a material testing center company | Commercial Services |
Nemis Technologies AG
Nemis Technologies AG Miscellaneous Commercial ServicesCommercial Services Develops diagnostic kits and solutions | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen